600750 Jiangzhong Pharmaceutical
- 26.07
- +0.23+0.89%
Jiangzhong Pharmaceutical News
Announcement of Jiangzhong Pharmaceutical on attending the 2023 Shanghai Main Board Health Group Results Briefing
Jiangzhong Pharmaceutical's announcement on the 2021 Restricted Stock Incentive Plan to reserve and grant part of the first release of the sales restriction period and unlocking and listing
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Jiangzhong Pharmaceutical
Legal Opinion of Guohao Lawyers (Shanghai) Firm on the 2023 Annual General Meeting of Shareholders of Jiangzhong Pharmaceutical
Announcement of Jiangzhong Pharmaceutical on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Jiangxi
Jiangzhong Pharmaceutical Co., Ltd. 2023 Annual General Meeting Meeting Meeting Materials
Announcement of Resolutions of the 21st Meeting of the 9th Board of Directors of Jiangzhong Pharmaceutical
Jiangzhong Pharmaceutical on the company's 2024 “Improve Quality, Increase Efficiency, and Value Return” action plan
Jiangzhong Pharmaceutical's announcement on the 2021 Restricted Stock Incentive Plan reserves the granting of some of the first unlocking conditions during the first unlocking period
Legal Opinion of Mr. Guo Hao (Shanghai) Firm on Jiangzhong Pharmaceutical's 2021 Restricted Stock Incentive Plan reserves and grants some of the first results of lifting the sales restrictions during the period of lifting the sales restrictions
Jiangzhong Pharmaceutical's Notice on Convening the 2023 Annual General Meeting of Shareholders
Inspection opinions of the board of supervisors on matters related to the 16th meeting of the 9th board of supervisors
Jiangzhong Pharmaceutical's announcement on holding a performance briefing for the first quarter of 2024
Announcement of Resolutions of the 16th Meeting of the 9th Board of Supervisors of Jiangzhong Pharmaceutical
Jiangzhong Pharmaceutical's 2024 First Quarter Report
Investor Relations Activity Schedule for April 2, 2024
Jiangzhong Pharmaceutical\'s indicative announcement on the 2023 results announcement of China Resources Pharmaceutical Group Co., Ltd., the indirect holding company of the controlling shareholder
Jiangzhong Pharmaceutical\'s announcement on the 2021 Restricted Stock Incentive Plan to repurchase and cancel some restricted stocks and adjust the repurchase price
Legal Opinion of Mr. Guo Hao (Shanghai) Office on the repurchase and cancellation of some restricted stocks in the 2021 Restricted Stock Incentive Plan of Jiangzhong Pharmaceutical Co., Ltd.
Jiangzhong Pharmaceutical\'s Notice to Creditors on Repurchase and Cancellation of Some Restricted Shares
Analysis
Price Target
No Data
